Exponent delivered results ahead of Wall Street expectations in Q4, with management crediting growth in both proactive and reactive consulting engagements. CEO Catherine Corrigan highlighted increased ...
Scientific consulting firm Exponent (NASDAQ:EXPO) reported revenue ahead of Wall Street’s expectations in Q4 CY2025, with ...
Exponent's Q4 2024 earnings and revenue exceeded forecasts. Stock price increased by 3.54% in after-hours trading. Full-year 2024 revenues grew by 4% to $558.5 million. The company reported a 28.4% ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results